Close

Ratings by BofA Securities (Jason Gerberry)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
5/14/2024 Fractyl Health Inc GUTS Maintain Buy
(N/A)
 
 
  Details
5/10/2024 Tarsus Pharmaceuticals TARS Maintain Buy
(N/A)
 
 
  Details
5/7/2024 Lyra Therapeutics LYRA Downgrade Underperform
(Buy)
0.52
(0.38)
-26.92% Details
5/2/2024 Alkermes ALKS Maintain Neutral
(N/A)
 
 
  Details
5/2/2024 Lyra Therapeutics LYRA Maintain Buy
(N/A)
 
 
  Details
4/17/2024 Intra-Cellular Therapies ITCI Maintain Buy
(N/A)
 
 
  Details
3/28/2024 Galapagos NV GLPG Downgrade Underperform
(Neutral)
32.95
(29.63)
-10.08% Details
2/28/2024 Tarsus Pharmaceuticals TARS Maintain Buy
(N/A)
 
 
  Details
2/28/2024 Amphastar Pharmaceuticals AMPH Maintain Buy
(N/A)
 
 
  Details
2/27/2024 Fractyl Health Inc GUTS New Coverage Buy
(N/A)
7.60
(7.06)
-7.11% Details
2/8/2024 bluebird bio BLUE Maintain Buy
(N/A)
 
 
  Details
2/6/2024 Vaxcyte PCVX Maintain Buy
(N/A)
 
 
  Details
1/12/2024 Axsome Therapeutics AXSM Maintain Neutral
(N/A)
 
 
  Details
1/12/2024 Teva Pharma TEVA Maintain Buy
(N/A)
 
 
  Details
1/10/2024 Arrowhead Pharma ARWR Maintain Buy
(N/A)
 
 
  Details
1/2/2024 ProKidney Corp. PROK Downgrade Neutral
(Buy)
1.78
(4.06)
128.09% Details
1/2/2024 Ionis Pharmaceuticals IONS Upgrade Buy
(Neutral)
50.59
(37.31)
-26.25% Details
1/2/2024 Harmony Biosciences Holdings Inc. HRMY Downgrade Underperform
(Neutral)
32.30
(29.03)
-10.12% Details
12/11/2023 bluebird bio BLUE Maintain Buy
(N/A)
 
 
  Details
12/4/2023 Arrowhead Pharma ARWR New Coverage Buy
(N/A)
23.17
(24.77)
6.91% Details
11/17/2023 Amphastar Pharmaceuticals AMPH New Coverage Neutral
(N/A)
56.17
(43.48)
-22.59% Details
11/15/2023 ProKidney Corp. PROK Maintain Buy
(N/A)
 
 
  Details
11/6/2023 Galapagos NV GLPG Maintain Neutral
(N/A)
 
 
  Details
11/3/2023 Karuna Therapeutics Inc. KRTX Maintain Buy
(N/A)
 
 
  Details
11/3/2023 Intra-Cellular Therapies ITCI Maintain Buy
(N/A)
 
 
  Details
10/23/2023 Ionis Pharmaceuticals IONS Upgrade Neutral
(Underperform)
46.16
(37.31)
-19.17% Details
10/23/2023 Viatris VTRS Downgrade Underperform
(Neutral)
9.30
(10.98)
18.06% Details
10/16/2023 Harmony Biosciences Holdings Inc. HRMY Maintain Neutral
(N/A)
 
 
  Details
9/13/2023 Lyra Therapeutics LYRA Maintain Buy
(N/A)
 
 
  Details
9/8/2023 Teva Pharma TEVA Maintain Buy
(N/A)
 
 
  Details
9/8/2023 Karuna Therapeutics Inc. KRTX Maintain Buy
(N/A)
 
 
  Details
9/5/2023 Axsome Therapeutics AXSM Maintain Neutral
(N/A)
 
 
  Details
8/29/2023 Oculis Holding AG OCS Maintain Buy
(N/A)
 
 
  Details
8/9/2023 Oculis Holding AG OCS Maintain Buy
(N/A)
 
 
  Details
8/9/2023 Cara Therapeutics CARA Maintain Underperform
(N/A)
 
 
  Details
8/9/2023 bluebird bio BLUE Maintain Buy
(N/A)
 
 
  Details
8/9/2023 Lyra Therapeutics LYRA Maintain Buy
(N/A)
 
 
  Details
8/9/2023 Vaxcyte PCVX Maintain Buy
(N/A)
 
 
  Details
8/9/2023 Mirati Therapeutics MRTX Maintain Neutral
(N/A)
 
 
  Details
8/8/2023 FibroGen FGEN Downgrade Underperform
(Neutral)
1.77
(1.20)
-32.2% Details
8/8/2023 Axsome Therapeutics AXSM Upgrade Buy
(Underperform)
71.09
(76.54)
7.67% Details
8/3/2023 Coherus Biosciences CHRS Maintain Neutral
(N/A)
 
 
  Details
8/3/2023 Teva Pharma TEVA Maintain Buy
(N/A)
 
 
  Details
7/19/2023 bluebird bio BLUE Upgrade Buy
(Neutral)
3.15
(1.03)
-67.3% Details
6/26/2023 FibroGen FGEN Downgrade Neutral
(Buy)
16.05
(1.20)
-92.52% Details
6/14/2023 Oculis Holding AG OCS New Coverage Buy
(N/A)
11.50
(11.98)
4.17% Details
5/16/2023 Cara Therapeutics CARA Maintain Underperform
(N/A)
 
 
  Details
5/10/2023 Xenon Pharmaceuticals XENE Maintain Buy
(N/A)
 
 
  Details
5/5/2023 Bausch Health Companies BHC Maintain Underperform
(N/A)
 
 
  Details
5/5/2023 Relay Therapeutics RLAY Maintain Buy
(N/A)
 
 
  Details
5/5/2023 Intra-Cellular Therapies ITCI Maintain Buy
(N/A)
 
 
  Details
5/5/2023 Karuna Therapeutics Inc. KRTX Maintain Buy
(N/A)
 
 
  Details
5/5/2023 Organon & Co. OGN Maintain Underperform
(N/A)
 
 
  Details
5/1/2023 Immunovant IMVT New Coverage Buy
(N/A)
16.14
(30.70)
90.21% Details
4/20/2023 Harmony Biosciences Holdings Inc. HRMY New Coverage Neutral
(N/A)
32.97
(29.03)
-11.95% Details
4/18/2023 Vaxcyte PCVX Maintain Buy
(N/A)
 
 
  Details
3/8/2023 Cara Therapeutics CARA Downgrade Underperform
(Neutral)
10.02
(0.75)
-92.51% Details
3/7/2023 Coherus Biosciences CHRS Maintain Neutral
(N/A)
 
 
  Details
2/28/2023 Vaxcyte PCVX Maintain Buy
(N/A)
 
 
  Details
2/28/2023 FibroGen FGEN Maintain Buy
(N/A)
 
 
  Details
1/9/2023 Exelixis EXEL Maintain Buy
(N/A)
 
 
  Details
1/5/2023 Organon & Co. OGN Maintain Underperform
(N/A)
 
 
  Details
1/5/2023 Federated National Holding FNHC Maintain Buy
(N/A)
 
 
  Details
1/5/2023 BeyondSpring Inc. BYSI Maintain Underperform
(N/A)
 
 
  Details
1/5/2023 FibroGen FGEN Upgrade Buy
(Neutral)
16.10
(1.20)
-92.55% Details
1/3/2023 Alkermes ALKS Maintain Neutral
(N/A)
 
 
  Details
12/13/2022 Arcellx Inc. ACLX New Coverage Buy
(N/A)
28.52
(53.62)
88.01% Details
12/13/2022 Mirati Therapeutics MRTX Maintain Neutral
(N/A)
 
 
  Details
12/9/2022 Mirati Therapeutics MRTX Maintain Neutral
(N/A)
 
 
  Details
12/9/2022 Exelixis EXEL Maintain Buy
(N/A)
 
 
  Details
12/8/2022 Mirati Therapeutics MRTX Maintain Neutral
(N/A)
 
 
  Details
11/28/2022 Mirati Therapeutics MRTX Maintain Neutral
(N/A)
 
 
  Details
11/15/2022 Arcellx Inc. ACLX Maintain Buy
(N/A)
 
 
  Details
11/8/2022 Viatris VTRS Maintain Neutral
(N/A)
 
 
  Details
10/14/2022 Jazz Pharmaceuticals JAZZ Maintain Buy
(N/A)
 
 
  Details
10/14/2022 Teva Pharma TEVA Maintain Buy
(N/A)
 
 
  Details
10/14/2022 Viatris VTRS Maintain Neutral
(N/A)
 
 
  Details
10/14/2022 Horizon Therapeutics HZNP Maintain Buy
(N/A)
 
 
  Details
10/14/2022 Axsome Therapeutics AXSM Maintain Underperform
(N/A)
 
 
  Details
10/14/2022 Intra-Cellular Therapies ITCI Maintain Buy
(N/A)
 
 
  Details
10/14/2022 Mirati Therapeutics MRTX Maintain Neutral
(N/A)
 
 
  Details
10/14/2022 Alkermes ALKS Upgrade Neutral
(Underperform)
22.72
(24.15)
6.29% Details
10/14/2022 Organon & Co. OGN Downgrade Underperform
(Neutral)
24.03
(21.80)
-9.28% Details
10/12/2022 DICE Therapeutics DICE Maintain Buy
(N/A)
 
 
  Details
9/29/2022 Jazz Pharmaceuticals JAZZ Maintain Buy
(N/A)
 
 
  Details
9/23/2022 ProKidney Corp. PROK New Coverage Buy
(N/A)
8.87
(4.06)
-54.23% Details
9/20/2022 bluebird bio BLUE Maintain Neutral
(N/A)
 
 
  Details
9/13/2022 Mirati Therapeutics MRTX Maintain Buy
(N/A)
 
 
  Details
8/29/2022 Xenon Pharmaceuticals XENE New Coverage Buy
(N/A)
36.97
(39.80)
7.65% Details
8/18/2022 Karuna Therapeutics Inc. KRTX Maintain Buy
(N/A)
 
 
  Details
8/18/2022 Relay Therapeutics RLAY New Coverage Buy
(N/A)
19.34
(6.64)
-65.67% Details
8/8/2022 Mirati Therapeutics MRTX Maintain Neutral
(N/A)
 
 
  Details
8/5/2022 Teva Pharma TEVA Upgrade Buy
(Neutral)
10.12
(16.29)
60.97% Details
8/5/2022 Organon & Co. OGN Downgrade Neutral
(Buy)
32.41
(24.03)
-25.86% Details
7/11/2022 Teva Pharma TEVA Maintain Neutral
(N/A)
 
 
  Details
7/11/2022 Intra-Cellular Therapies ITCI Maintain Buy
(N/A)
 
 
  Details
7/11/2022 Ionis Pharmaceuticals IONS Maintain Underperform
(N/A)
 
 
  Details
7/11/2022 Horizon Therapeutics HZNP Maintain Buy
(N/A)
 
 
  Details
7/11/2022 Coherus Biosciences CHRS Maintain Neutral
(N/A)
 
 
  Details
7/11/2022 Bausch Health Companies BHC Maintain Underperform
(N/A)
 
 
  Details
6/29/2022 Axsome Therapeutics AXSM Maintain Underperform
(N/A)
 
 
  Details
6/29/2022 Mirati Therapeutics MRTX Maintain Neutral
(N/A)
 
 
  Details
6/7/2022 Mirati Therapeutics MRTX Maintain Neutral
(N/A)
 
 
  Details
6/2/2022 Axsome Therapeutics AXSM Maintain Buy
(N/A)
 
 
  Details
6/1/2022 Vaxcyte PCVX Maintain Buy
(N/A)
 
 
  Details
5/17/2022 Finch Therapeutics Group Inc. FNCH Maintain Buy
(N/A)
 
 
  Details
5/17/2022 Teva Pharma TEVA Upgrade Neutral
(Underperform)
7.91
(16.29)
105.94% Details
3/28/2022 Karuna Therapeutics Inc. KRTX Maintain Buy
(N/A)
 
 
  Details
3/8/2022 bluebird bio BLUE Maintain Buy
(N/A)
 
 
  Details
3/1/2022 Arcellx Inc. ACLX New Coverage Buy
(N/A)
19.14
(53.62)
180.15% Details
3/1/2022 Viatris VTRS Downgrade Neutral
(Buy)
11.01
(10.98)
-0.27% Details
2/1/2022 Ionis Pharmaceuticals IONS Downgrade Underperform
(Buy)
31.80
(37.31)
17.33% Details
2/1/2022 Mirati Therapeutics MRTX Upgrade Neutral
(Underperform)
119.30
(58.70)
-50.8% Details
12/8/2021 Ionis Pharmaceuticals IONS Maintain Buy
(N/A)
 
 
  Details
12/2/2021 BeyondSpring Inc. BYSI Downgrade Underperform
(Buy)
12.77
(2.68)
-79.01% Details
11/16/2021 Alkermes ALKS Maintain Underperform
(N/A)
 
 
  Details
11/16/2021 bluebird bio BLUE Maintain Neutral
(N/A)
 
 
  Details
11/12/2021 Organon & Co. OGN Maintain Buy
(N/A)
 
 
  Details
11/11/2021 FibroGen FGEN Maintain Neutral
(N/A)
 
 
  Details
11/10/2021 Jazz Pharmaceuticals JAZZ Maintain Buy
(N/A)
 
 
  Details
11/9/2021 Cara Therapeutics CARA Maintain Neutral
(N/A)
 
 
  Details
11/9/2021 Viatris VTRS Maintain Buy
(N/A)
 
 
  Details
11/9/2021 Alkermes ALKS Maintain Underperform
(N/A)
 
 
  Details
11/8/2021 Galapagos NV GLPG Maintain Neutral
(N/A)
 
 
  Details
10/26/2021 Horizon Therapeutics HZNP Maintain Buy
(N/A)
 
 
  Details
10/18/2021 Ionis Pharmaceuticals IONS Maintain Buy
(N/A)
 
 
  Details
10/11/2021 DICE Therapeutics DICE New Coverage Buy
(N/A)
26.49
(47.55)
79.5% Details
9/17/2021 Horizon Therapeutics HZNP Maintain Buy
(N/A)
 
 
  Details
9/13/2021 BeyondSpring Inc. BYSI Maintain Buy
(N/A)
 
 
  Details
9/2/2021 Alkermes ALKS Downgrade Underperform
(Neutral)
31.25
(22.72)
-27.3% Details
9/1/2021 Organon & Co. OGN New Coverage Buy
(N/A)
33.89
(21.80)
-35.67% Details
8/4/2021 Bausch Health Companies BHC Maintain Underperform
(N/A)
 
 
  Details
8/4/2021 Jazz Pharmaceuticals JAZZ Maintain Buy
(N/A)
 
 
  Details
7/16/2021 FibroGen FGEN Downgrade Neutral
(Buy)
24.84
(1.20)
-95.17% Details
6/28/2021 FibroGen FGEN Maintain Buy
(N/A)
 
 
  Details
6/22/2021 Jazz Pharmaceuticals JAZZ Maintain Buy
(N/A)
 
 
  Details
6/22/2021 Tarsus Pharmaceuticals TARS Maintain Buy
(N/A)
 
 
  Details
5/25/2021 Eli Lilly LLY Maintain Buy
(N/A)
 
 
  Details
3/30/2021 Vaxcyte PCVX Maintain Buy
(N/A)
 
 
  Details
3/11/2021 bluebird bio BLUE Maintain Neutral
(N/A)
 
 
  Details
3/4/2021 Coherus Biosciences CHRS Maintain Neutral
(N/A)
 
 
  Details
2/24/2021 Jazz Pharmaceuticals JAZZ Maintain Buy
(N/A)
 
 
  Details
2/9/2021 Horizon Therapeutics HZNP Maintain Buy
(N/A)
 
 
  Details
1/11/2021 BeyondSpring Inc. BYSI New Coverage Buy
(N/A)
12.62
(2.68)
-78.76% Details
12/11/2020 Alkermes ALKS Maintain Neutral
(N/A)
 
 
  Details
12/1/2020 Horizon Therapeutics HZNP Maintain Buy
(N/A)
 
 
  Details
11/3/2020 Horizon Therapeutics HZNP Maintain Buy
(N/A)
 
 
  Details
10/26/2020 Mirati Therapeutics MRTX Maintain Neutral
(N/A)
 
 
  Details
10/21/2020 Cara Therapeutics CARA Maintain Neutral
(N/A)
 
 
  Details
10/12/2020 Arena Pharma ARNA Maintain Buy
(N/A)
 
 
  Details
8/21/2020 Galapagos NV GLPG Maintain Underperform
(N/A)
 
 
  Details
8/6/2020 Horizon Therapeutics HZNP Maintain Buy
(N/A)
 
 
  Details
7/22/2020 Arena Pharma ARNA Maintain Buy
(N/A)
 
 
  Details
7/7/2020 Vaxcyte PCVX New Coverage Buy
(N/A)
29.38
(74.57)
153.81% Details
6/19/2020 Eli Lilly LLY Maintain Buy
(Buy)
 
 
  Details
5/26/2020 Horizon Therapeutics HZNP Maintain Buy
(N/A)
 
 
  Details
4/22/2020 Eli Lilly LLY Maintain Buy
(N/A)
 
 
  Details
4/22/2020 Cara Therapeutics CARA Maintain Neutral
(N/A)
 
 
  Details
3/26/2020 Galapagos NV GLPG Maintain Underperform
(N/A)
 
 
  Details
2/25/2020 Horizon Therapeutics HZNP Maintain Buy
(N/A)
 
 
  Details
2/14/2020 Alkermes ALKS Downgrade Neutral
(Buy)
17.65
(24.15)
36.83% Details
2/13/2020 Teva Pharma TEVA Maintain Underperform
(N/A)
 
 
  Details
1/31/2020 Jazz Pharmaceuticals JAZZ Maintain Buy
(N/A)
 
 
  Details
1/13/2020 Exelixis EXEL Maintain Buy
(N/A)
 
 
  Details
1/13/2020 Exelixis EXEL Maintain Buy
(N/A)
 
 
  Details
12/31/2019 Ionis Pharmaceuticals IONS Maintain Buy
(N/A)
 
 
  Details
11/13/2019 Exelixis EXEL New Coverage Buy
(N/A)
15.34
(20.91)
36.31% Details
11/13/2019 Arena Pharma ARNA New Coverage Neutral
(N/A)
46.17
(41.50)
-10.11% Details
10/17/2019 Eli Lilly LLY New Coverage Buy
(N/A)
109.70
(770.00)
601.91% Details
10/10/2019 Bristol-Myers Squibb Co. BMY Maintain Neutral
(N/A)
 
 
  Details
9/12/2019 Jazz Pharmaceuticals JAZZ Maintain Buy
(N/A)
 
 
  Details
9/10/2019 Eli Lilly LLY Maintain Neutral
(N/A)
 
 
  Details
9/5/2019 Mallinckrodt plc MNK Maintain Underperform
(N/A)
 
 
  Details
9/3/2019 Bristol-Myers Squibb Co. BMY Maintain Neutral
(N/A)
 
 
  Details
8/20/2019 Nabriva Therapeutics AG NBRV Maintain Buy
(N/A)
 
 
  Details
7/30/2019 Pfizer PFE Downgrade Neutral
(Buy)
41.45
(36.50)
-11.94% Details
6/25/2019 Abbvie ABBV Maintain Neutral
(N/A)
 
 
  Details
6/21/2019 Merck MRK Maintain Buy
(N/A)
 
 
  Details
5/30/2019 Teva Pharma TEVA Downgrade Underperform
(Neutral)
9.70
(16.29)
67.94% Details
5/1/2019 Merck MRK Maintain Buy
(N/A)
 
 
  Details
4/1/2019 Pfizer PFE Maintain Buy
(N/A)
 
 
  Details
3/27/2019 Jazz Pharmaceuticals JAZZ Maintain Buy
(N/A)
 
 
  Details
3/20/2019 Banco de Chile BCH New Coverage Underperform
(N/A)
31.19
(24.54)
-21.32% Details
3/7/2019 Allergen AGN Maintain Buy
(N/A)
 
 
  Details
2/19/2019 Bristol-Myers Squibb Co. BMY Maintain Neutral
(N/A)
 
 
  Details
1/30/2019 Allergen AGN Maintain Buy
(N/A)
 
 
  Details
1/30/2019 Pfizer PFE Maintain Buy
(N/A)
 
 
  Details
1/28/2019 Abbvie ABBV Maintain Neutral
(N/A)
 
 
  Details
1/25/2019 Bristol-Myers Squibb Co. BMY Maintain Neutral
(N/A)
 
 
  Details
1/15/2019 Cara Therapeutics CARA New Coverage Neutral
(N/A)
15.83
(0.75)
-95.26% Details
1/3/2019 Mylan MYL Maintain Buy
(N/A)
 
 
  Details
1/3/2019 Allergen AGN Maintain Buy
(N/A)
 
 
  Details
1/3/2019 Eli Lilly LLY Maintain Neutral
(N/A)
 
 
  Details
1/3/2019 Merck MRK Maintain Buy
(N/A)
 
 
  Details
1/3/2019 Abbvie ABBV Downgrade Neutral
(Buy)
89.23
(166.42)
86.51% Details
1/3/2019 Teva Pharma TEVA Upgrade Buy
(Underperform)
15.85
(9.70)
-38.8% Details
12/12/2018 Foamix Pharmaceuticals FOMX New Coverage Buy
(N/A)
4.00
(2.99)
-25.25% Details
11/30/2018 Alkermes ALKS Maintain Buy
(N/A)
 
 
  Details
11/6/2018 Mylan MYL Upgrade Buy
(Neutral)
31.37
(15.86)
-49.44% Details
10/16/2018 Spero Therapeutics SPRO Downgrade Underperform
(Neutral)
9.60
(1.59)
-83.44% Details
10/4/2018 Abbvie ABBV Maintain Buy
(N/A)
 
 
  Details
8/27/2018 Nabriva Therapeutics AG NBRV Maintain Buy
(Buy)
 
 
  Details
8/27/2018 Paratek Pharmaceuticals PRTK New Coverage Neutral
(N/A)
10.35
(2.23)
-78.45% Details